In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Increasing The Odds of New Pharma Product Access: Engage Payors During Product Development

Executive Summary

Earlier and more systematic engagement between pharmaceutical companies and health plans during the drug development process can enable better strategies and product profiles at launch and during early market adoption. To explore these concerns and opportunities from both pharmaceutical companies' and health plans' perspectives, Booz & Company recently conducted independent research consisting of a quantitative survey and in-depth interviews with chief medical officers and medical directors of several leading health plans and pharmacy benefits managers . The quantitative survey captured the views and experiences of medical and pharmacy directors from 20 leading national and regional health plans on the value of engagement during development and the effectiveness of how 20 leading pharmaceutical companies engage during development.

Related Content

Creating Value In Pharma-Health Plan Collaborations
Booz VP Advises Pharma: Show Value To Gain Market Access
Booz VP Advises Pharma: Show Value To Gain Market Access





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts